Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2023
AbbVie files patent lawsuit against BeiGene over Brukinsa
AbbVie’s Pharmacyclics unit filed a lawsuit against BeiGene in federal court in Delaware, alleging that BeiGene’s Brukinsa infringes a patent on AbbVie’s Imbruvica. AbbVie sought a declaratory judgment of infringement and damages; BeiGene said it would vigorously defend against the allegations.